CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors

Moderna enters in vivo CAR-T with autoimmune asset

Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026

Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies

TScan Therapeutics Advances TSC-101 Toward Pivotal Trial

FREE to Attend for Drug Developers, Small Scale Biotech & Academics*

Session Breaks for Lunch

Session Breaks for Lunch

12:15 pm - Thursday 17th September 2026